Simplex Trading’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,257
| Closed | -$42.6K | – | 9023 |
|
|
2025
Q4 | $42.6K | Buy |
3,257
+1,040
| +47% | +$12.4K | ﹤0.01% | 5809 |
|
|
2025
Q3 | $16K | Buy |
2,217
+1,957
| +753% | +$13.2K | ﹤0.01% | 7511 |
|
|
2025
Q2 | $1K | Buy |
260
+191
| +277% | +$926 | ﹤0.01% | 8253 |
|
|
2025
Q1 | $0 | Sell |
69
-661
| -91% | -$4.62K | ﹤0.01% | 8488 |
|
|
2024
Q4 | $6K | Buy |
730
+590
| +421% | +$6.27K | ﹤0.01% | 7476 |
|
|
2024
Q3 | $1K | Sell |
140
-5,640
| -98% | -$62.7K | ﹤0.01% | 8128 |
|
|
2024
Q2 | $52K | Sell |
5,780
-90,901
| -94% | -$887K | ﹤0.01% | 6038 |
|
|
2024
Q1 | $1.36M | Buy |
96,681
+81,001
| +517% | +$1.01M | ﹤0.01% | 2799 |
|
|
2023
Q4 | $120K | Buy |
15,680
+14,615
| +1,372% | +$80.8K | ﹤0.01% | 5193 |
|
|
2023
Q3 | $7K | Buy |
1,065
+803
| +306% | +$6.85K | ﹤0.01% | 7394 |
|
|
2023
Q2 | $2K | Buy |
+262
| New | +$3.02K | ﹤0.01% | 8358 |
|
|
2023
Q1 | – | Sell |
-52,310
| Closed | -$707K | – | 8979 |
|
|
2022
Q4 | $778K | Buy |
+52,310
| New | +$539K | ﹤0.01% | 2720 |
|
|
2022
Q3 | – | Sell |
-77
| Closed | -$516 | – | 9856 |
|
|
2022
Q2 | $0 | Sell |
77
-1,258
| -94% | -$5.64K | ﹤0.01% | 9906 |
|
|
2022
Q1 | $8K | Buy |
+1,335
| New | +$7.95K | ﹤0.01% | 9026 |
|
|
2021
Q3 | – | Sell |
-79
| Closed | -$1K | – | 9748 |
|
|
2021
Q2 | $1K | Sell |
79
-919
| -92% | -$11.9K | ﹤0.01% | 9790 |
|
|
2021
Q1 | $17K | Buy |
998
+14
| +1% | +$253 | ﹤0.01% | 7570 |
|
|
2020
Q4 | $12K | Buy |
+984
| New | +$17.5K | ﹤0.01% | 7286 |
|
Simplex Trading's ATXS Position: Q1 2026 in Review
Simplex Trading sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 3,257 shares — an estimated $42.6K sold.
Simplex Trading first reported a position in ATXS in Q4 2020 and held it in 17 quarters. The position peaked at $1.36M in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Simplex Trading reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 3,257 Astria Therapeutics shares in Q1 2026, an estimated $42.6K.
- Simplex Trading first reported a position in Astria Therapeutics in Q4 2020 and held it in 17 quarters.
- Simplex Trading's Astria Therapeutics position peaked at $1.36M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.